According to the Zhitong Finance App, Lee's Pharmaceutical Company (00950.HK) announced its 2026 interim results, with revenue of approximately HK$797 million, up 14.6% year on year; profit attributable to company owners was HK$95.14 million, up 41.4% year on year; profit per share was HK$16.14 cents, with an interim dividend of HK3.5 cents per share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.